| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.01B | 3.64B | 3.02B | 5.14B | 3.90B |
| Gross Profit | -200.22M | 483.31M | 544.77M | 1.30B | 944.14M |
| EBITDA | -551.31M | 411.94M | 530.39M | 1.18B | 786.56M |
| Net Income | -1.71B | 207.10M | 334.90M | 888.07M | 540.68M |
Balance Sheet | |||||
| Total Assets | 4.90B | 6.63B | 5.70B | 5.69B | 4.98B |
| Cash, Cash Equivalents and Short-Term Investments | 5.59M | 476.36M | 2.31B | 3.14B | 2.65B |
| Total Debt | 734.72M | 826.85M | 407.25M | 495.31M | 575.98M |
| Total Liabilities | 1.27B | 1.38B | 652.52M | 972.85M | 1.04B |
| Stockholders Equity | 3.62B | 5.26B | 5.05B | 4.71B | 3.94B |
Cash Flow | |||||
| Free Cash Flow | -551.81M | -2.01B | -715.64M | 719.43M | 619.04M |
| Operating Cash Flow | -327.36M | -93.66M | -154.54M | 875.61M | 650.89M |
| Investing Cash Flow | -94.71M | -1.35B | -1.35B | -146.24M | -25.97M |
| Financing Cash Flow | -35.70M | 396.41M | -123.24M | -240.15M | 938.29M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$306.25M | 6.76 | 6.01% | 7.76% | 14.80% | -56.27% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | HK$273.00M | -1.63 | -4.18% | 9.76% | -44.29% | -598.72% | |
42 Neutral | HK$314.51M | 24.82 | 6.01% | ― | -5.88% | ― | |
41 Neutral | HK$76.58M | -0.04 | ― | ― | ― | ― | |
39 Underperform | HK$192.99M | -0.57 | 32.54% | ― | -45.11% | 16.34% | |
39 Underperform | HK$246.86M | -0.47 | -40.16% | ― | -27.42% | -80.52% |